KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Tax Provisions (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 16 years of Tax Provisions data on record, last reported at $1.5 million in Q4 2025.

  • For Q4 2025, Tax Provisions rose 155.3% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.8 million, up 129.03%, while the annual FY2025 figure was $1.8 million, 128.94% up from the prior year.
  • Tax Provisions reached $1.5 million in Q4 2025 per IONS's latest filing, up from $213000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $11.4 million in Q1 2023 and bottomed at -$3.6 million in Q3 2024.
  • Average Tax Provisions over 5 years is $2.0 million, with a median of $316000.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: soared 2232.86% in 2023, then tumbled 154.85% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $349000.0 in 2021, then skyrocketed by 2231.52% to $8.1 million in 2022, then dropped by 19.86% to $6.5 million in 2023, then plummeted by 140.96% to -$2.7 million in 2024, then skyrocketed by 155.3% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $1.5 million in Q4 2025, $213000.0 in Q3 2025, and -$20000.0 in Q2 2025.